focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiaceutics Share News (DXRX)

Share Price Information for Diaceutics (DXRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 114.50
Bid: 113.00
Ask: 116.00
Change: 4.50 (4.09%)
Spread: 3.00 (2.655%)
Open: 112.00
High: 117.00
Low: 110.00
Prev. Close: 110.00
DXRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

Fri, 27th Jan 2023 18:56

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Diaceutics PLC - Belfast-based testing laboratories company - Signs two enterprise-level, multi-disease data engagements with two pharmaceutical companies with a combined value of USD7 million over a two-year period. Says that the agreements are for its subscription data services. Reports that revenue in 2022 increased 44% to GBP20.0 million from GBP13.9 million in 2021. Adds that revenue is materially ahead of market expectations. Expects earnings before interest, tax, depreciation, and amortization to be in line with market expectations, with an with Ebitda margin similar to 2021. Attributes growth to demand from its pharmaceutical and life science customers.

----------

ICG-Longbow Senior Secured UK Property Debt Investments Ltd - Resolves to return 5.50 pence per ordinary share to shareholders, being GBP6.7 million in total based on the current number of ordinary shares in issue.

----------

Ilika PLC - Hampshire, England-based solid-state battery technology provider - Reports that it is leading a 24-month GBP8.2 million Faraday Battery Challenge collaboration programme "to integrate high silicon content electrodes into its Goliath solid-state batteries to enable automotive level performance". Adds that it will receive a GBP2.8 million grant over the 24-month programme.

----------

Mercia Asset Management PLC - Warwickshire, England-based, regionally-focused asset manager - Says that the final payment of GBP2.1million in relation to its acquisition of a venture capital trust fund management business from NVM Private Equity LLP has become payable. Plans to pay through the issue of 6.5 million new deferred consideration shares at 32.45p each. Expects the deferred consideration shares to start trading on AIM on January 31.

----------

Time Out Group PLC - media and hospitality business - Signs a lease deal with Klepierre Real Estate Espana SLU to open market in Barcelona in the first half of 2024. Says that Time Out Market Barcelona will be located in the Maremagnum shopping and leisure destination in the Port Vell, across 56,500 square feet. Says that this opening increases the line-up of new sites to eight markets in development which are set to open between 2023 and 2027. Does not disclose any details about the lease. "Barcelona is globally regarded as one of the top food destinations in the world and is a perfect fit for our brand. We are excited to bring Time Out Market to this fabulous, vibrant city together with our partners Klepierre and Estrella Damm. We now have an incredibly strong line-up of new Markets that will open in the next few years and with interest from landlords and real estate developers stronger than ever, we expect to further accelerate the signing of new Markets in the year ahead," Co-CEO Jay Coldren says.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical drug discovery and development company - Proposes a private placing to raise EUR11.0 million through an accelerated book-building directed at institutional and other investors. Adds that the subscription price per placing share is to be determined on the basis of the bids received in the bookbuild in euros. Says the Finland Branch of Carnegie Investment Bank AB is acting as sole bookrunner and lead manager in the placing.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
16 May 2024 14:32

EARNINGS AND TRADING: Michelmersh continues with positive order intake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
16 May 2024 10:09

Diaceutics strikes two new enterprise-wide agreements

(Sharecast News) - Technology and solutions provider Diaceutics has struck two new enterprise-wide agreements, taking the total number to six engagements, across 29 separate therapeutic brands.

Read more
9 Apr 2024 12:34

Diaceutics appoints new VP of marketing

(Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.

Read more
2 Apr 2024 19:02

TRADING UPDATES: Roadside shares suspended; Adnams looks for funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
21 Mar 2024 13:58

Diaceutics upgrades diagnositc commercialisation platform, DXRX

(Alliance News) - Diaceutics PLC on Thursday said it has launched a "significant upgrade" to its DXRX platform.

Read more
27 Feb 2024 14:18

TRADING UPDATES: Sondrel wins USD23 million contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
14 Feb 2024 13:52

IN BRIEF: Diaceutics announces new marketing partnership with KPMG

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Announces strategic alliance with KPMG LLC, which provides tax, audit and advisory services and commercialisation solutions for life sciences and healthcare companies. Diaceutics says the partnership will facilitate joint marketing of commercialisation solutions to life science customers for commercialisation of precision medicines.

Read more
30 Jan 2024 11:16

Diaceutics maintains "momentum" for year ahead on revenue rise in 2023

(Alliance News) - Diaceutics PLC on Tuesday highlighted the extent of market opportunities for its product, after seeing annual revenue rise despite tough macroeconomic conditions.

Read more
26 Sep 2023 11:37

Diaceutics revenue grows but loss widens, CEO Keeling to step down

(Alliance News) - Diaceutics PLC on Tuesday reported strong revenue growth in its first half despite a widened loss, as well as strong demand from new customers despite a cautious atmosphere in the pharmaceutical sector.

Read more
29 Aug 2023 13:16

IN BRIEF: Diaceutics launches daily alerts for DXRX platform

Diaceutics PLC - Belfast-based testing laboratories company - Launches daily alerts update for its DXRX Signal platform, which it says will allow clients to identify patients who previously weren't receiving "the most appropriate treatment" due to lack of timely data. Adds that it has identified over 46,000 patients this year for its biopharma clients.

Read more
25 Jul 2023 12:12

Diaceutics interim revenue jumps as order book grows to GBP24 million

(Alliance News) - Diaceutics PLC on Tuesday reaffirmed its full year outlook, after delivering revenue growth of 32% in the first six months of the year.

Read more
6 Jun 2023 13:47

Director dealings: BAT, Diaceutics execs make investments

(Sharecast News) - Among the list of director buys on Tuesday was British American Tobacco, after its chief executive picked up more than a quarter-of-a-million pounds worth of shares.

Read more
5 Jun 2023 11:09

IN BRIEF: Diaceutics shares surge on contract win with top US firm

Diaceutics PLC - Belfast-based testing laboratories company - Wins a three-year enterprise contract with an unnamed "top 10 global pharmaceutical company" based in the US. Says the contract will bring in USD10.1 million in revenue over its term, with options to "significantly" increase its scope and value. Revenue will be recognised monthly, with immediate effect. Says revenue will be recognised on a monthly basis. It will deliver a range of subscription data services via its DXRX platform.

Read more
26 Apr 2023 20:28

DIRECTOR DEALINGS: Energean shareholder sells GBP6.6 million in shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

Read more
17 Apr 2023 14:16

IN BRIEF: Diaceutics achieves increase in annual revenue and profit

Diaceutics PLC - Belfast-based testing laboratories company - Posts revenue of GBP19.5 million for 2022, up 40% from GBP13.9 million in 2021. Pretax profit is GBP564,000, up from GBP462,000, as operating profit increases to GBP575,000 from GBP550,000 a year earlier. Administrative expenses increase to GBP16.3 million from GBP11.9 million. Earnings before interest, tax, depreciation and amortisation amounts to GBP3.6 million, up from GBP2.3 million. Order book stands at GBP16.9 million at year-end, compared to GBP1.8 million a year earlier.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.